Cost-utility Analysis of Outpatient Manual Vacuum Aspiration Versus Operating Room Electric Aspiration for the Management of First-trimester Miscarriage (ASPIR)
Cost-utility Analysis of Outpatient Manual Vacuum Aspiration Versus Operating Room Electric Aspiration for the Management of First-trimester Miscarriage (ASPIR Study)
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Miscarriage occurs in approximately 15% of pregnancies during the first trimester. In France, surgical management usually involves electric aspiration in the operating room under anesthesia, associated with hospital admission. Manual vacuum aspiration (MVA) is widely used in low-resource settings and for induced abortion, with demonstrated safety and patient satisfaction. This multicenter randomized controlled trial compares outpatient MVA under local anesthesia and inhaled analgesia versus electric aspiration (EA) under anesthesia in the operating room.
The primary objective is to assess the incremental cost-utility ratio (ICUR, cost per QALY) at 3 months. Secondary outcomes include complications, pain, satisfaction, quality of life, and fertility at 12 months. The study anticipates enrolling 860 participants across multiple centers in France.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Thibault Thubert, Pr
- Telefonnummer: +33253482443
- E-post: thibault.thubert@chu-nantes.fr
Studieorter
-
-
-
Nantes, Frankrike, 44000
- CHU de Nantes
-
Kontakt:
- Thibault Thubert, Pr
- Telefonnummer: +33 2 53 48 24 43
- E-post: thibault.thubert@chu-nantes.fr
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Female, aged 18-44 years
- Ultrasound-confirmed first-trimester miscarriage requiring surgical management
- Gestational age between 5 and 12 weeks of amenorrhea
- Incomplete spontaneous abortion or ongoing non-viable pregnancy
- Patient able to provide oral informed consent
Exclusion Criteria:
- Complete expulsion of pregnancy (endometrial thickness < 15 mm)
- Choice of medical treatment with misoprostol
- Elective termination of pregnancy
- Unwanted pregnancy
- Pregnancy of unknown location, molar pregnancy
- Known uterine malformation
- Prior surgical aspiration for the current pregnancy
- Intrauterine device in place
- Contraindicating medications (e.g. anticoagulants)
- Protected adults (under guardianship)
- Inability to complete study questionnaires
- Lack of social security coverage
- Haemorrhagic miscarriage
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Hälsovårdsforskning
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Manual vacuum aspiration (MVA)
Outpatient manual vacuum aspiration under local anesthesia and inhaled analgesia (MEOPA).
|
Performed in consultation under local anesthesia and inhaled analgesia, using a manual vacuum aspirator and appropriate cannula.
Post-procedure pelvic ultrasound to confirm complete evacuation.
|
|
Aktiv komparator: Electric aspiration in the operating room under general or regional anesthesia. Electric aspiration
Electric aspiration in the operating room under general or regional anesthesia.
Performed in the operating room under general or regional anesthesia, using an electric suction device and appropriate cannula.
Post-procedure pelvic ultrasound to confirm complete evacuation.
|
Performed in the operating room under general or regional anesthesia, using an electric suction device and appropriate cannula.
Post-procedure pelvic ultrasound to confirm complete evacuation.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Incremental cost-utility ratio (ICUR)
Tidsram: 3 months
|
Incremental cost per quality-adjusted life year (QALY) gained of outpatient MVA compared to operating room EA, from a collective perspective.
|
3 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Annual net financial benefit for health insurance over up to 5 years of different development scenarios for manual vacuum aspiration in consultation for the management of pregnancies terminated before 12 weeks of gestation
Tidsram: up to 5 years
|
Annual net financial benefit for health insurance over up to 5 years of different development scenarios for manual vacuum aspiration in consultation for the management of pregnancies terminated before 12 weeks of gestation
|
up to 5 years
|
|
To compare the two management strategies in terms of success and intraoperative and postoperative complications
Tidsram: 1 month
|
To compare the two management strategies in terms of success and intraoperative and postoperative complications
|
1 month
|
|
To assess patient satisfaction
Tidsram: day 1 and 2
|
To assess patient satisfaction: A numerical scale (NS) (0-10) on Days 1 and 2. |
day 1 and 2
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Tidsram: days 0, 1,7 and 1 and 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Pain via NS (a scale from 0 to 10) on Day 0 (before the procedure, 30 min after the procedure +/- 30 min), Days 1, 7, 1, and 3 |
days 0, 1,7 and 1 and 3 months
|
|
The risk factors for failure
Tidsram: 3 months
|
The risk factors for failure at M3 studied will be: the term of the terminated pregnancy, patient compliance, patient satisfaction (numerical scale (from 0 to 10), patient characteristics (age).
|
3 months
|
|
Satisfaction with the patient's care by medical staff
Tidsram: day 0 and 1 month
|
Satisfaction with the patient's care by medical staff will be assessed using an EN (numerical scale 0 to 10) at D0 and M1
|
day 0 and 1 month
|
|
Patient having been pregnant in days
Tidsram: 12 months
|
Patient having been pregnant at 12 months, pregnancy outcome and time to conception in days.
|
12 months
|
|
To assess patient satisfaction
Tidsram: day 1 and 2 and 1 month et 3 month
|
To assess patient satisfaction: A numerical scale (NS) (0-10) on Days 1 and 2. HADS (Hospital Anxiety and Depression Scale) and PCL-5 questionnaires at 1 and 3 months |
day 1 and 2 and 1 month et 3 month
|
|
To assess patient satisfaction
Tidsram: 1 and 3 months
|
HADS (Hospital Anxiety and Depression Scale) and PCL-5 questionnaires at 1 and 3 months
|
1 and 3 months
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Tidsram: Day 0, 1,7 and 1 and 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Pain via NS (a scale from 0 to 10) on Day 0 (before the procedure, 30 min after the procedure +/- 30 min), Days 1, 7, 1, and 3 |
Day 0, 1,7 and 1 and 3 months
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Tidsram: Day 0 to 7
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Analgesic consumption (type, quantity, and duration) from Day 0 to 7 |
Day 0 to 7
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Tidsram: Day 0 to 7
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●Number of pads used per day (Higham score) from Days 1 to 7 |
Day 0 to 7
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Tidsram: Day 0
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of:
|
Day 0
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Tidsram: 1 and 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction) ● Postoperative complications will include:Perioperative bleeding greater than 200 ml (Higham score), infection (temperature >38°C and pelvic symptoms) …classified according to the Calvien and Dindo criteria, at M1, the persistence of abnormal bleeding, trophoblastic retention, at M3, the presence of amenorrhea outside the context of a new pregnancy |
1 and 3 months
|
|
To compare the two strategies (electric suction versus manual vacuum kit suction)
Tidsram: 1 et 3 months
|
To compare the two strategies (electric suction versus manual vacuum kit suction), measurement of: ●quality of life questionnaires EQ-5D-5L, PGI-I at M1 and M3 |
1 et 3 months
|
Samarbetspartners och utredare
Sponsor
Utredare
- Huvudutredare: Thibault Thubert, Pr, Nantes university hospital
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- RC24_0471
- 2025-A00724-45 (Annan identifierare: ANSM)
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
IPD-planbeskrivning
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .